Janssen's Invokana has received the Food and Drug Administration's blessing, making it the first oral diabetes treatment approved for cardiovascular events.
Jazz Pharmaceuticals' FDA approval of a new indication for Xyrem gives narcolepsy patients age seven years old and older a treatment for cataplexy, or excessive daytime sleepiness,
Sun Pharma is introducing its Ilumya injectable, which has been approved by the Food and Drug Administration, for the treatment of moderate-to-severe plaque psoriasis in adults.